Business
LevelJump Healthcare Announces Grant of Options
Toronto, Ontario--(Newsfile Corp. - January 11, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (...
About this update from Leveljump Healthcare Corp.
[{"type":"text","content":"LevelJump Healthcare Announces Grant of OptionsToronto, Ontario--(Newsfile Corp. - January 11, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) (\"LevelJump\" or the \"Company\"), a Canadian leader in B2B telehealth solutions, announces that it has granted 2,650,000 stock options to certain directors and officers of the Company.In light of the new Option grant, the Company would also like to announce that as of December 21, 2023 and December 31, 2023, 3,900,000 previous directors and officers Options have expired.Of the Options granted:An aggregate of 2,650,000 Options at an exercisable price of $0.20 were granted to certain directors of the Company expiring December 31, 2026 and are subject to 12 month vesting provisions.About LevelJump HealthcareLevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.ON BEHALF OF THE BOARD OF DIRECTORS OFLEVELJUMP HEALTHCARE CORP.Mitchell GeislerChief Executive OfficerCaitlin-Robyn DensmoreInvestor Relations [email protected](437) 214-1568CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATIONThis news release contains \"forward-looking information\" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The...